AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
4
Echo: “Employees have become very good at identifying performative culture”
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news

Sanofi

6 stories about Sanofi
CTech The growth conference Katie Kushnir Ventura

“People learn, people develop”: Sanofi Israel’s HR Head sees “only positives” in AI

10.06.25|Amy Shapiro
Speaking with CTech at the Israel Growth Conference, Sanofi Israel’s Katie Kushnir Ventura shared how the pharmaceutical giant is using AI to improve its operations and support employees through upskilling and easier access to digital resources.
מגזין מנהלים ריצ'רד פרנסיס מנכ"ל טבע

Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook

30.01.25|Sophie Shulman
Despite a strong 80% gain in 2024, Teva’s stock dropped after the company revealed disappointing profitability and cash flow forecasts.
ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva’s 10-year turnaround takes shape with stunning trial results

18.12.24|Sophie Shulman
Duvakitug signals a brighter future for the Israeli pharma giant. 
מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva shares jump as its most promising drug shows exceptional trial results

17.12.24|Sophie Shulman
Duvakitug, designed to treat colitis and Crohn’s disease, exceeded expectations and positions Teva to compete in the $28 billion global market for inflammatory bowel disease treatments.
מייסדי Nucleai

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
עומרי שור מנכ"ל מדיסייף

Medisafe raises $30 million in Series C led by pharma giant Sanofi

25.02.21|Meir Orbach
The company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors